 |
dabrafenib |
|---|---|
| Trade Name | Tafinler |
| Orphan Indication | Non-small cell lung cancer |
| USA Market Approval | USA |
| USA Designation Date | 2014-10-20 00:00:00 |
| Sponsor | Novartis Pharmaceuticals Corporation;1 Health Plaza;East Hanover, New Jersey, 07936 |
Related Access Program